TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19202954

Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjusted-dose warfarin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enoxaparin once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carotid angioplasty/stenting vs. endarterectomy
Number of subjects: 0
Study: 15926135

Group type: EXPERIMENTAL
Intervention: Pregabalin at doses of 150 mg to 600 mg per day
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Pregabalin at 600 mg per day
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1052
Study: 12566019

Group type: EXPERIMENTAL
Intervention: FDT perimetry
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Polarimetry (GDx)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: FDT and GDx combined
Number of subjects: 307

Group type: COMPARATOR
Intervention: GDx
Number of subjects: 307
Study: 12920842

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (group EA, n = 16)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: General anesthesia (group GA, n = 16)
Number of subjects: 32
Study: 9861552

Group type: COMPARATOR
Intervention: Methylphenidate (5.0-30.0 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: d-Amphetamine (2.5-20.0 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Methylphenidate and d-Amphetamine
Number of subjects: 17
Study: 7879963

Group type: EXPERIMENTAL
Intervention: Hydrophilic guidewires
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional guidewires
Number of subjects: 33
Study: 2244440

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger (HME) used in 10 patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no HME) with 10 patients
Number of subjects: 20
Study: 27463

Group type: EXPERIMENTAL
Intervention: 5 mg mepindolol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80 mg propranolol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 15 mg pindolol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30071142

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV), performed three times a week for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 29284465

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (3 times per week)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Donepezil hydrochloride (5 mg/day for first 4 weeks, then 10 mg/day thereafter)
Number of subjects: 87
Study: 25544195

Group type: EXPERIMENTAL
Intervention: Hypericum 900-1500 mg/day
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Sertraline 50-100 mg/day
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 23358929

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation (CRT group; Arm 1) - EBRT to pelvis (45 Gy) with concurrent oral Capecitabine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Radiation therapy with boost (RT with boost group; Arm 2) - EBRT to pelvis (45 Gy) alone followed by 20 Gy localized radiotherapy boost
Number of subjects: 90
Study: 21307717

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.15 mg/kg every 6 hours for 4 days
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 19821654

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 480

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 480
Study: 17080281

Group type: EXPERIMENTAL
Intervention: Z-plasty repair
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional surgery (delayed healing by secondary intention)
Number of subjects: 72
Study: 15636229

Group type: EXPERIMENTAL
Intervention: Scanning laser polarimetry (NFA/GDx, software version 1.0.16)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Standard automated perimetry (SAP-HFA, 24-2 threshold test)
Number of subjects: 28
Study: 11728676

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra) 50 mg for 2 weeks, increased to 100 mg if needed; duration of treatment was 12 weeks.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo; duration of treatment was 12 weeks.
Number of subjects: 60
Study: 9234024

Group type: EXPERIMENTAL
Intervention: Cafetiere coffee (5-6 cups/day)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Coffee oil (equivalent to 10-20 cups of unfiltered coffee)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Purified mixture of cafestol and kahweol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Cafestol (10 mg/d)
Number of subjects: 63
Study: 8354108

Group type: EXPERIMENTAL
Intervention: 10 micrograms
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 5 micrograms
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 2.5 micrograms
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 10 micrograms (1 year after primary immunization)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 5 micrograms (1 year after primary immunization)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 2.5 micrograms (1 year after primary immunization)
Number of subjects: 206
Study: 3497379

Group type: EXPERIMENTAL
Intervention: Orally administered amoxicillin
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 31677985

Group type: EXPERIMENTAL
Intervention: Suction (S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-pull (SP)
Number of subjects: 0
Study: 30077969

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 56
Study: 29216937

Group type: EXPERIMENTAL
Intervention: PPI group (PPI < 1.4 for diagnosis, PPI > 2 for treatment)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: PPI group
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 25363415

Group type: EXPERIMENTAL
Intervention: Tarafenacin 0.4 mg
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Tarafenacin 0.2 mg
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 235
Study: 23248234

Group type: EXPERIMENTAL
Intervention: Cheese and vegetables (combined snack)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Potato chips (control)
Number of subjects: 201
Study: 21306309

Group type: EXPERIMENTAL
Intervention: Brain-sparing flow (defined as a middle cerebral artery-to-umbilical artery pulsatility index ratio of <1.08)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Brain-sparing flow
Number of subjects: 126
Study: 19348537

Group type: EXPERIMENTAL
Intervention: Emotionally neutral faces perceived to possess various personality traits
Number of subjects: 0
Study: 17845648

Group type: EXPERIMENTAL
Intervention: 2% lidocaine (40 ml)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 4% lidocaine (40 ml)
Number of subjects: 27
Study: 15050863

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation with pulse width 250 micros
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation with pulse width 500 micros
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation with pulse width 130 micros
Number of subjects: 12
Study: 11383646

Group type: EXPERIMENTAL
Intervention: Our formula: MHE=13.2 D/W(0.5)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Heiken's formula: MHE=CD/W
Number of subjects: 104
Study: 9587911

Group type: EXPERIMENTAL
Intervention: Chronic exposure to carbon disulfide (9.36‐23.4 mg/m2)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not exposed to carbon disulfide)
Number of subjects: 65
Study: 7912539

Group type: EXPERIMENTAL
Intervention: BRL35135 8 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Salbutamol 8 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nadolol 20 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Bisoprolol 5 mg
Number of subjects: 8
Study: 2645808

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg midazolam with 0.015-0.02 mg/kg atropine (Group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg midazolam with 0.015-0.02 mg/kg atropine (Group II)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 80
Study: 53330

Group type: EXPERIMENTAL
Intervention: Bromocriptine (2-5 mg twice daily)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Quinoestrol (4 mg single dose)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 30548573

Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyric acid (GHB) administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 20
Study: 27923500

Group type: EXPERIMENTAL
Intervention: Preoperative educational telephone call
Number of subjects: 104

Group type: COMPARATOR
Intervention: No preoperative educational telephone call (Control)
Number of subjects: 104
Study: 25533903

Group type: EXPERIMENTAL
Intervention: Exercise training (EX)
Number of subjects: 22
Study: 23419004

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tryptophan-balanced control condition (BAL)
Number of subjects: 20
Study: 21521895

Group type: EXPERIMENTAL
Intervention: 5 mL deionized water
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 2.7% w/v citric acid
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Seltzer water
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 50:50 diluted ethanol/water
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Older age group (60+ years)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Supertasters
Number of subjects: 80
Study: 18444872

Group type: EXPERIMENTAL
Intervention: CPG 7909 adjuvant plus HBV vaccine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (HBV vaccine without CPG 7909)
Number of subjects: 38
Study: 17058781

Group type: EXPERIMENTAL
Intervention: Non verbal instruction
Number of subjects: 120

Group type: COMPARATOR
Intervention: Verbal instruction
Number of subjects: 120
Study: 12574791

Group type: EXPERIMENTAL
Intervention: Liquorice consumption (100 g daily for 4 weeks, 150 mg glycyrrhetinic acid)
Number of subjects: 0
Study: 10959541

Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMP; 10 and 20 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: ethanol (EtOH; 0.2, 0.4, and 0.8 g/kg)
Number of subjects: 37
Study: 9379784

Group type: EXPERIMENTAL
Intervention: 10 mg oral buspirone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 30 mg oral buspirone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 1588521

Group type: EXPERIMENTAL
Intervention: Exercise-based rehabilitation programme with advice about return to normal activity
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard hospital care (Control)
Number of subjects: 110
Study: 3898825

Group type: EXPERIMENTAL
Intervention: 20 mcg vaccine
Number of subjects: 43

Group type: COMPARATOR
Intervention: 40 mcg vaccine
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 20 mcg vaccine (normal volunteers)
Number of subjects: 43
Study: 30287107

Group type: EXPERIMENTAL
Intervention: Multipoint percutaneous ethanol injection (MPEI)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Super-selective angiograms followed by embolization with gelfoam (EFAG) plus MPEI
Number of subjects: 117
Study: 29231216

Group type: EXPERIMENTAL
Intervention: Aronia-citrus juice (ACJ) intake (200 mL per day for 45 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 16
Study: 26478208

Group type: EXPERIMENTAL
Intervention: escitalopram 10 mg/day + single-dose i.v. ketamine (0.5 mg/kg over 40 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: escitalopram 10 mg/day + placebo (0.9% i.v. saline)
Number of subjects: 30
Study: 25199862

Group type: EXPERIMENTAL
Intervention: Non-submerged implants
Number of subjects: 20

Group type: COMPARATOR
Intervention: Submerged implants
Number of subjects: 20
Study: 23109700

Group type: EXPERIMENTAL
Intervention: Acupuncture plus usual care
Number of subjects: 302

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 302
Study: 19795111

Group type: EXPERIMENTAL
Intervention: p.m.-a.m. group (sleep included)
Number of subjects: 0

Group type: COMPARATOR
Intervention: a.m.-p.m. group (no sleep)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (young and old)
Number of subjects: 0
Study: 17593904

Group type: EXPERIMENTAL
Intervention: Fructose beverage (50 g)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Glucose beverage (50 g)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Whey protein beverage (50 g)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Whey + Fructose beverage (25 g each)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Energy intake after 4 h (all beverages)
Number of subjects: 28
Study: 14999213

Group type: EXPERIMENTAL
Intervention: Biofeedback treatment (6 sessions of abdominal breath training, heart and respiratory physiologic feedback, daily breathing practice)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 63
Study: 11686825

Group type: EXPERIMENTAL
Intervention: 0.09% chlorhexidine + 1% PVP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.09% chlorhexidine + 3% PVP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.09% chlorhexidine + 5% PVP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.09% chlorhexidine + 7% PVP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine + 10% PVP
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Essential oil product
Number of subjects: 66
Study: 9459398

Group type: EXPERIMENTAL
Intervention: i.v. ceftriaxone
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: oral cefixime
Number of subjects: 38

Group type: COMPARATOR
Intervention: Baseline serum IL‐6 values >400 pg/ml
Number of subjects: 38
Study: 7948058

Group type: EXPERIMENTAL
Intervention: 20 mg yohimbine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3215290

Group type: EXPERIMENTAL
Intervention: 1.5, 3.0 and 6.0 megaunits (MU) of interferon A per day
Number of subjects: 412

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 412
Study: 30427997

Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 17095

Group type: EXPERIMENTAL
Intervention: GDF-15
Number of subjects: 17095

Group type: EXPERIMENTAL
Intervention: C-reactive protein, GDF-15, cystatin-C
Number of subjects: 17095
Study: 27323346

Group type: EXPERIMENTAL
Intervention: RT + cetuximab
Number of subjects: 181

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 181
Study: 26216033

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with defibrillator (CRT-D)
Number of subjects: 1263
Study: 23743804

Group type: EXPERIMENTAL
Intervention: STITCH2-care (simplified treatment algorithm featuring single-pill combinations)
Number of subjects: 1750

Group type: COMPARATOR
Intervention: Guidelines-care (following current Canadian guidelines)
Number of subjects: 1750

Group type: EXPERIMENTAL
Intervention: STITCH2-care
Number of subjects: 1750
Study: 20883456

Group type: EXPERIMENTAL
Intervention: SQ-standardized HDM SCIT
Number of subjects: 54
Study: 19068113

Group type: EXPERIMENTAL
Intervention: Closed-loop control based on fuzzy logic
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (clinician's discretion)
Number of subjects: 39
Study: 16425137

Group type: EXPERIMENTAL
Intervention: rA2cp Delta NS2 (10^7.0 pfu)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rA2cp248/404 Delta NS2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rA2cp530/1009 Delta NS2
Number of subjects: 0
Study: 14596683

Group type: EXPERIMENTAL
Intervention: Enoximone (1.5 mg/kg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Dobutamine (5 and 10 micrograms/kg/min)
Number of subjects: 26
Study: 10852450

Group type: EXPERIMENTAL
Intervention: Endotoxin (2.0-3.0 ng/kg) in E2-replaced women
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ACTH infusion (Cortrosyn, 50 microg/h) in E2-replaced women
Number of subjects: 10

Group type: COMPARATOR
Intervention: Endotoxin (2.0-3.0 ng/kg) in unreplaced women
Number of subjects: 10
Study: 9356764

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g/day plus 4 g/day glucose)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (24 g/day glucose)
Number of subjects: 80
Study: 1539814

Group type: EXPERIMENTAL
Intervention: Electrical single twitch stimulation at the spinal nerve dermatome one segment rostrad of the proximal extent of sensory paralysis (Group A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Electrical twitch stimulation at the anterior crural region (Group B)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No stimulation (Control Group C)
Number of subjects: 18
Study: 3882125

Group type: EXPERIMENTAL
Intervention: Isotretinoin (40 mg daily for 2 months)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Etretinate (50 mg daily for 2 months)
Number of subjects: 16
Study: 31144165

Group type: EXPERIMENTAL
Intervention: Automatic position-adaptive stimulation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Manual stimulation
Number of subjects: 18
Study: 28991039

Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise (60%-65% 1-repetition maximum, two sets of 15-20 repetitions)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Heavy-load resistance exercise (85%-90% 1-repetition maximum, three sets of 5-8 repetitions)
Number of subjects: 21
Study: 27247055

Group type: EXPERIMENTAL
Intervention: 16Gy boost to the tumour bed
Number of subjects: 864

Group type: COMPARATOR
Intervention: 26Gy boost to the tumour bed
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Both interventions (16Gy and 26Gy)
Number of subjects: 864
Study: 26475663

Group type: COMPARATOR
Intervention: Telehealth service delivery model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional full assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telehealth risk assessment and screening
Number of subjects: 0
Study: 22423669

Group type: EXPERIMENTAL
Intervention: Behavior modification program (nutritional education, modifying dietary habits, exercise programs, nutritional facts for parents, exercises 3 days a week)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Behavior modification program
Number of subjects: 152
Study: 20357588

Group type: COMPARATOR
Intervention: Ponseti technique
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: French physical therapy (PT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined group (moderate and severe clubfeet)
Number of subjects: 33
Study: 18564079

Group type: EXPERIMENTAL
Intervention: Preterm-targeted screening programme
Number of subjects: 202

Group type: COMPARATOR
Intervention: NHMRC universal child health screening programme
Number of subjects: 202
Study: 15573366

Group type: EXPERIMENTAL
Intervention: Minimally invasive parathyroidectomy (MIP) under local anaesthesia, n = 25
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional bilateral cervical exploration (BCE) under general anaesthesia, n = 25
Number of subjects: 50
Study: 12454831

Group type: EXPERIMENTAL
Intervention: PAC7 (pantoprazole 40 mg, amoxicillin 1000 mg, clarithromycin 500 mg, all twice daily for 7 days)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: PBTM7 (pantoprazole 40 mg twice daily, bismuth subcitrate 108 mg, tetracycline 500 mg, both 4 times daily, metronidazole 200 mg 3 times daily and 400 mg at night for 7 days)
Number of subjects: 405

Group type: COMPARATOR
Intervention: BTM14 (bismuth subcitrate 108 mg and tetracycline 500 mg, both 4 times daily, metronidazole 200 mg 3 times daily and 400 mg at night for 14 days)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: PAC7
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: PBTM7
Number of subjects: 405

Group type: COMPARATOR
Intervention: BTM14
Number of subjects: 405
Study: 10037123

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma from whole-blood preparation, adjusted to 10 x 10(9) platelets per mL
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Platelets collected by apheresis, adjusted to 20 x 10(9) platelets per mL
Number of subjects: 19
Study: 8748394

Group type: EXPERIMENTAL
Intervention: Oxazepam 20 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oxazepam 40 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oxazepam (both doses)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Time-on-task
Number of subjects: 18
Study: 1777788

Group type: EXPERIMENTAL
Intervention: Low intensity arm exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low intensity leg exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Supine rest
Number of subjects: 10
Study: 6337364

Group type: EXPERIMENTAL
Intervention: Glutathione bicarbonate Ringer's (GBR) intraocular irrigation fluid
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ringer's solution
Number of subjects: 80
Study: 31733780

Group type: EXPERIMENTAL
Intervention: Combined exercise group (sensorimotor training + traditional exercises)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional exercise group
Number of subjects: 53
Study: 29683560

Group type: EXPERIMENTAL
Intervention: Hands-on ultrasound training
Number of subjects: 43

Group type: COMPARATOR
Intervention: No hands-on training
Number of subjects: 43
Study: 26843092

Group type: EXPERIMENTAL
Intervention: 3 g CLA (75 % c9,t11‐CLA, 87 % purity)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (safflower oil)
Number of subjects: 29
Study: 23306948

Group type: EXPERIMENTAL
Intervention: Plasma rich in growth factors (PRGF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no PRGF)
Number of subjects: 20
Study: 22304357

Group type: EXPERIMENTAL
Intervention: Trombopol 75 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aspirin cardio 100 mg
Number of subjects: 30